Regulatory News

Filters

Date / Time Source Ticker Company Sector Market Cap Announcement
02May25 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Half-year Report
30Apr25 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Confirmation of European Orphan Drug Designation
14Apr25 12:22 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Correction - Exercise of Warrants
14Apr25 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Exercise of Warrants
09Apr25 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - NXP002 Update
20Mar25 11:10 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Result of AGM
28Feb25 12:30 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Total Voting Rights
14Feb25 14:18 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Posting of Annual Report and Notice of AGM
30Jan25 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - £168,750 Placing
29Jan25 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Annual Results for period ended 30 September 2024
28Jan25 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - NXP002 ODD Application Submitted
13Jan25 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - NXP002 Orphan Drug Designation Draft Application
29Nov24 17:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Total Voting Rights
05Nov24 14:25 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Director/PDMR Dealings
04Nov24 10:17 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Result of General Meeting
16Oct24 13:37 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Publication of Prospectus & Notice of GM
20Sep24 14:24 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - £300,000 Fundraise
18Jun24 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Half-year Report
17Jun24 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Patent Update
19Mar24 14:39 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Result of AGM
01Mar24 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Subscription to raise £150,000
15Jan24 11:30 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Posting of Annual Report and Notice of AGM
03Jan24 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Results for the period ended 30 September 2023
18Dec23 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - NXP001 Update
23Oct23 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Notice of Allowance of NXP002 Patent in Japan
18Sep23 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - NXP001 Update
24Aug23 13:22 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Result of Annual General Meeting
31Jul23 14:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Notice of AGM
02Jun23 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Investor Online Q&A
25May23 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Change of Auditor
22May23 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Unaudited Interim Report
18May23 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - NXP002 Inflammation and Duration of Action Update
17Apr23 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Subscription to raise £70,000 & issue of Warrants
27Mar23 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - NXP002 Update
13Mar23 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Change of Accounting Reference Date
15Feb23 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - NXP002 Update
20Dec22 13:00 DGAP-News NFX:LON Nuformix Plc Health £3.27m EQS-News: Nuformix hoping to 'initiate discussions with major pharma' in 2023
20Dec22 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - NXP004 Update
13Dec22 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Half-year Report
05Dec22 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Resignation of Auditor
04Nov22 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Investor Webinar
23Sep22 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - NXP002 Update
25Aug22 14:39 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Result of AGM
10Aug22 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - NXP002 Completion of Tolerability Studies
01Aug22 12:13 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Posting of Annual Report and Notice of AGM
28Jul22 07:01 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Board Changes
28Jul22 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Annual Results for the year ended 31 March 2022
05Jul22 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - NXP002 data to be presented at 2022 ERS Congress
29Jun22 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - NXP004 Update
27Jun22 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - NXP002 Update
31May22 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Directorate Change
30May22 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Corporate Update
12Apr22 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Second tranche of Lanstead subscription shares
28Mar22 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - NXP004 Patent
02Mar22 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Appointment of Dr Dan Gooding as Consultant
01Mar22 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Change of Auditor
08Feb22 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Oxilio NXP-001 formulation development contract
01Feb22 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Adviser Appointments
31Jan22 14:09 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Director/PDMR Shareholding
31Jan22 11:05 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Result of General Meeting
17Jan22 09:56 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Posting of Circular and Notice of General Meeting
10Jan22 16:23 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Director/PDMR Shareholding
14Dec21 07:01 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Subscription to raise £1.65 million
14Dec21 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Half year Report
25Nov21 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Positive pre-clinical data on NXP002
12Nov21 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - NXP004 patent application filing
09Nov21 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Directorate Change
16Sep21 14:14 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Director/PDMR Shareholding - Replacement
16Sep21 12:47 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Director/PDMR Shareholding
13Sep21 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Licensing agreement with Oxilio for NXP001
24Aug21 11:57 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Result of AGM
23Jul21 13:35 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Posting of Annual Report and Notice of AGM
22Jul21 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Letter to shareholders re: Dr Anne Brindley
21Jul21 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Directorate Change
15Jul21 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Final results for the year ended 31 March 2021
07Jun21 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Notice of Allowance of Patent in US
01Jun21 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Project update - Progress on NXP002 and NXP004
24May21 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix PLC - Directorate Changes
29Mar21 11:27 RNS NFX:LON Nuformix Plc Health £3.27m Result of General Meeting and Total Voting Rights
22Mar21 07:00 RNS NFX:LON Nuformix Plc Health £3.27m NXP001 (Oncology) - Exercise of Option by Oxilio
11Mar21 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Initiation of research by Allenby Capital
10Mar21 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Proposed Placing to raise £1.565 million
02Mar21 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Research Results
10Feb21 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Directorate Change
22Dec20 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Appointment of Broker
22Dec20 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Half-year Report
07Dec20 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Appointment of Chief Executive Officer
02Dec20 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Appointment of Non-Executive Director
24Nov20 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Appointment of Non-Executive Director
07Oct20 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Placing and Strategic Update
24Sep20 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Exclusive Option Agreement for NXP001
20Aug20 11:33 RNS NFX:LON Nuformix Plc Health £3.27m Result of AGM
19Aug20 14:24 RNS NFX:LON Nuformix Plc Health £3.27m Results Pre-clinical Pilot Study in IPF for NXP004
28Jul20 12:14 RNS NFX:LON Nuformix Plc Health £3.27m Annual Report and Notice of AGM 2020
22Jul20 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Preliminary Results for year ended 31 March 2020
01Jul20 11:15 RNS NFX:LON Nuformix Plc Health £3.27m Notification of Major Holdings
22Jun20 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Board Change
27May20 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Business Update
27May20 07:00 RNS NFX:LON Nuformix Plc Health £3.27m Nuformix and VistaGen Announce CNS Agreement
30Mar20 15:42 RNS NFX:LON Nuformix Plc Health £3.27m Notiication of Major Share Holding
Date / Time Source Company % Chg
02May25 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Half-year Report
30Apr25 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Confirmation of European Orphan Drug Designation
14Apr25 12:22 RNS Nuformix Plc 3.99%
Nuformix PLC - Correction - Exercise of Warrants
14Apr25 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Exercise of Warrants
09Apr25 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - NXP002 Update
20Mar25 11:10 RNS Nuformix Plc 3.99%
Nuformix PLC - Result of AGM
28Feb25 12:30 RNS Nuformix Plc 3.99%
Nuformix PLC - Total Voting Rights
14Feb25 14:18 RNS Nuformix Plc 3.99%
Nuformix PLC - Posting of Annual Report and Notice of AGM
30Jan25 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - £168,750 Placing
29Jan25 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Annual Results for period ended 30 September 2024
28Jan25 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - NXP002 ODD Application Submitted
13Jan25 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - NXP002 Orphan Drug Designation Draft Application
29Nov24 17:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Total Voting Rights
05Nov24 14:25 RNS Nuformix Plc 3.99%
Nuformix PLC - Director/PDMR Dealings
04Nov24 10:17 RNS Nuformix Plc 3.99%
Nuformix PLC - Result of General Meeting
16Oct24 13:37 RNS Nuformix Plc 3.99%
Nuformix PLC - Publication of Prospectus & Notice of GM
20Sep24 14:24 RNS Nuformix Plc 3.99%
Nuformix PLC - £300,000 Fundraise
18Jun24 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Half-year Report
17Jun24 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Patent Update
19Mar24 14:39 RNS Nuformix Plc 3.99%
Nuformix PLC - Result of AGM
01Mar24 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Subscription to raise £150,000
15Jan24 11:30 RNS Nuformix Plc 3.99%
Nuformix PLC - Posting of Annual Report and Notice of AGM
03Jan24 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Results for the period ended 30 September 2023
18Dec23 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - NXP001 Update
23Oct23 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Notice of Allowance of NXP002 Patent in Japan
18Sep23 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - NXP001 Update
24Aug23 13:22 RNS Nuformix Plc 3.99%
Nuformix PLC - Result of Annual General Meeting
31Jul23 14:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Notice of AGM
02Jun23 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Investor Online Q&A
25May23 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Change of Auditor
22May23 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Unaudited Interim Report
18May23 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - NXP002 Inflammation and Duration of Action Update
17Apr23 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Subscription to raise £70,000 & issue of Warrants
27Mar23 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - NXP002 Update
13Mar23 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Change of Accounting Reference Date
15Feb23 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - NXP002 Update
20Dec22 13:00 DGAP-News Nuformix Plc 3.99%
EQS-News: Nuformix hoping to 'initiate discussions with major pharma' in 2023
20Dec22 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - NXP004 Update
13Dec22 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Half-year Report
05Dec22 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Resignation of Auditor
04Nov22 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Investor Webinar
23Sep22 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - NXP002 Update
25Aug22 14:39 RNS Nuformix Plc 3.99%
Nuformix PLC - Result of AGM
10Aug22 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - NXP002 Completion of Tolerability Studies
01Aug22 12:13 RNS Nuformix Plc 3.99%
Nuformix PLC - Posting of Annual Report and Notice of AGM
28Jul22 07:01 RNS Nuformix Plc 3.99%
Nuformix PLC - Board Changes
28Jul22 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Annual Results for the year ended 31 March 2022
05Jul22 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - NXP002 data to be presented at 2022 ERS Congress
29Jun22 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - NXP004 Update
27Jun22 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - NXP002 Update
31May22 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Directorate Change
30May22 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Corporate Update
12Apr22 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Second tranche of Lanstead subscription shares
28Mar22 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - NXP004 Patent
02Mar22 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Appointment of Dr Dan Gooding as Consultant
01Mar22 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Change of Auditor
08Feb22 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Oxilio NXP-001 formulation development contract
01Feb22 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Adviser Appointments
31Jan22 14:09 RNS Nuformix Plc 3.99%
Nuformix PLC - Director/PDMR Shareholding
31Jan22 11:05 RNS Nuformix Plc 3.99%
Nuformix PLC - Result of General Meeting
17Jan22 09:56 RNS Nuformix Plc 3.99%
Nuformix PLC - Posting of Circular and Notice of General Meeting
10Jan22 16:23 RNS Nuformix Plc 3.99%
Nuformix PLC - Director/PDMR Shareholding
14Dec21 07:01 RNS Nuformix Plc 3.99%
Nuformix PLC - Subscription to raise £1.65 million
14Dec21 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Half year Report
25Nov21 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Positive pre-clinical data on NXP002
12Nov21 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - NXP004 patent application filing
09Nov21 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Directorate Change
16Sep21 14:14 RNS Nuformix Plc 3.99%
Nuformix PLC - Director/PDMR Shareholding - Replacement
16Sep21 12:47 RNS Nuformix Plc 3.99%
Nuformix PLC - Director/PDMR Shareholding
13Sep21 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Licensing agreement with Oxilio for NXP001
24Aug21 11:57 RNS Nuformix Plc 3.99%
Nuformix PLC - Result of AGM
23Jul21 13:35 RNS Nuformix Plc 3.99%
Nuformix PLC - Posting of Annual Report and Notice of AGM
22Jul21 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Letter to shareholders re: Dr Anne Brindley
21Jul21 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Directorate Change
15Jul21 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Final results for the year ended 31 March 2021
07Jun21 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Notice of Allowance of Patent in US
01Jun21 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Project update - Progress on NXP002 and NXP004
24May21 07:00 RNS Nuformix Plc 3.99%
Nuformix PLC - Directorate Changes
29Mar21 11:27 RNS Nuformix Plc 3.99%
Result of General Meeting and Total Voting Rights
22Mar21 07:00 RNS Nuformix Plc 3.99%
NXP001 (Oncology) - Exercise of Option by Oxilio
11Mar21 07:00 RNS Nuformix Plc 3.99%
Initiation of research by Allenby Capital
10Mar21 07:00 RNS Nuformix Plc 3.99%
Proposed Placing to raise £1.565 million
02Mar21 07:00 RNS Nuformix Plc 3.99%
Research Results
10Feb21 07:00 RNS Nuformix Plc 3.99%
Directorate Change
22Dec20 07:00 RNS Nuformix Plc 3.99%
Appointment of Broker
22Dec20 07:00 RNS Nuformix Plc 3.99%
Half-year Report
07Dec20 07:00 RNS Nuformix Plc 3.99%
Appointment of Chief Executive Officer
02Dec20 07:00 RNS Nuformix Plc 3.99%
Appointment of Non-Executive Director
24Nov20 07:00 RNS Nuformix Plc 3.99%
Appointment of Non-Executive Director
07Oct20 07:00 RNS Nuformix Plc 3.99%
Placing and Strategic Update
24Sep20 07:00 RNS Nuformix Plc 3.99%
Exclusive Option Agreement for NXP001
20Aug20 11:33 RNS Nuformix Plc 3.99%
Result of AGM
19Aug20 14:24 RNS Nuformix Plc 3.99%
Results Pre-clinical Pilot Study in IPF for NXP004
28Jul20 12:14 RNS Nuformix Plc 3.99%
Annual Report and Notice of AGM 2020
22Jul20 07:00 RNS Nuformix Plc 3.99%
Preliminary Results for year ended 31 March 2020
01Jul20 11:15 RNS Nuformix Plc 3.99%
Notification of Major Holdings
22Jun20 07:00 RNS Nuformix Plc 3.99%
Board Change
27May20 07:00 RNS Nuformix Plc 3.99%
Business Update
27May20 07:00 RNS Nuformix Plc 3.99%
Nuformix and VistaGen Announce CNS Agreement
30Mar20 15:42 RNS Nuformix Plc 3.99%
Notiication of Major Share Holding
Date / Time Company % Chg
02May25 07:00 Nuformix Plc 3.99%
Nuformix PLC - Half-year Report
30Apr25 07:00 Nuformix Plc 3.99%
Nuformix PLC - Confirmation of European Orphan Drug Designation
14Apr25 12:22 Nuformix Plc 3.99%
Nuformix PLC - Correction - Exercise of Warrants
14Apr25 07:00 Nuformix Plc 3.99%
Nuformix PLC - Exercise of Warrants
09Apr25 07:00 Nuformix Plc 3.99%
Nuformix PLC - NXP002 Update
20Mar25 11:10 Nuformix Plc 3.99%
Nuformix PLC - Result of AGM
28Feb25 12:30 Nuformix Plc 3.99%
Nuformix PLC - Total Voting Rights
14Feb25 14:18 Nuformix Plc 3.99%
Nuformix PLC - Posting of Annual Report and Notice of AGM
30Jan25 07:00 Nuformix Plc 3.99%
Nuformix PLC - £168,750 Placing
29Jan25 07:00 Nuformix Plc 3.99%
Nuformix PLC - Annual Results for period ended 30 September 2024
28Jan25 07:00 Nuformix Plc 3.99%
Nuformix PLC - NXP002 ODD Application Submitted
13Jan25 07:00 Nuformix Plc 3.99%
Nuformix PLC - NXP002 Orphan Drug Designation Draft Application
29Nov24 17:00 Nuformix Plc 3.99%
Nuformix PLC - Total Voting Rights
05Nov24 14:25 Nuformix Plc 3.99%
Nuformix PLC - Director/PDMR Dealings
04Nov24 10:17 Nuformix Plc 3.99%
Nuformix PLC - Result of General Meeting
16Oct24 13:37 Nuformix Plc 3.99%
Nuformix PLC - Publication of Prospectus & Notice of GM
20Sep24 14:24 Nuformix Plc 3.99%
Nuformix PLC - £300,000 Fundraise
18Jun24 07:00 Nuformix Plc 3.99%
Nuformix PLC - Half-year Report
17Jun24 07:00 Nuformix Plc 3.99%
Nuformix PLC - Patent Update
19Mar24 14:39 Nuformix Plc 3.99%
Nuformix PLC - Result of AGM
01Mar24 07:00 Nuformix Plc 3.99%
Nuformix PLC - Subscription to raise £150,000
15Jan24 11:30 Nuformix Plc 3.99%
Nuformix PLC - Posting of Annual Report and Notice of AGM
03Jan24 07:00 Nuformix Plc 3.99%
Nuformix PLC - Results for the period ended 30 September 2023
18Dec23 07:00 Nuformix Plc 3.99%
Nuformix PLC - NXP001 Update
23Oct23 07:00 Nuformix Plc 3.99%
Nuformix PLC - Notice of Allowance of NXP002 Patent in Japan
18Sep23 07:00 Nuformix Plc 3.99%
Nuformix PLC - NXP001 Update
24Aug23 13:22 Nuformix Plc 3.99%
Nuformix PLC - Result of Annual General Meeting
31Jul23 14:00 Nuformix Plc 3.99%
Nuformix PLC - Notice of AGM
02Jun23 07:00 Nuformix Plc 3.99%
Nuformix PLC - Investor Online Q&A
25May23 07:00 Nuformix Plc 3.99%
Nuformix PLC - Change of Auditor
22May23 07:00 Nuformix Plc 3.99%
Nuformix PLC - Unaudited Interim Report
18May23 07:00 Nuformix Plc 3.99%
Nuformix PLC - NXP002 Inflammation and Duration of Action Update
17Apr23 07:00 Nuformix Plc 3.99%
Nuformix PLC - Subscription to raise £70,000 & issue of Warrants
27Mar23 07:00 Nuformix Plc 3.99%
Nuformix PLC - NXP002 Update
13Mar23 07:00 Nuformix Plc 3.99%
Nuformix PLC - Change of Accounting Reference Date
15Feb23 07:00 Nuformix Plc 3.99%
Nuformix PLC - NXP002 Update
20Dec22 13:00 Nuformix Plc 3.99%
EQS-News: Nuformix hoping to 'initiate discussions with major pharma' in 2023
20Dec22 07:00 Nuformix Plc 3.99%
Nuformix PLC - NXP004 Update
13Dec22 07:00 Nuformix Plc 3.99%
Nuformix PLC - Half-year Report
05Dec22 07:00 Nuformix Plc 3.99%
Nuformix PLC - Resignation of Auditor
04Nov22 07:00 Nuformix Plc 3.99%
Nuformix PLC - Investor Webinar
23Sep22 07:00 Nuformix Plc 3.99%
Nuformix PLC - NXP002 Update
25Aug22 14:39 Nuformix Plc 3.99%
Nuformix PLC - Result of AGM
10Aug22 07:00 Nuformix Plc 3.99%
Nuformix PLC - NXP002 Completion of Tolerability Studies
01Aug22 12:13 Nuformix Plc 3.99%
Nuformix PLC - Posting of Annual Report and Notice of AGM
28Jul22 07:01 Nuformix Plc 3.99%
Nuformix PLC - Board Changes
28Jul22 07:00 Nuformix Plc 3.99%
Nuformix PLC - Annual Results for the year ended 31 March 2022
05Jul22 07:00 Nuformix Plc 3.99%
Nuformix PLC - NXP002 data to be presented at 2022 ERS Congress
29Jun22 07:00 Nuformix Plc 3.99%
Nuformix PLC - NXP004 Update
27Jun22 07:00 Nuformix Plc 3.99%
Nuformix PLC - NXP002 Update
31May22 07:00 Nuformix Plc 3.99%
Nuformix PLC - Directorate Change
30May22 07:00 Nuformix Plc 3.99%
Nuformix PLC - Corporate Update
12Apr22 07:00 Nuformix Plc 3.99%
Nuformix PLC - Second tranche of Lanstead subscription shares
28Mar22 07:00 Nuformix Plc 3.99%
Nuformix PLC - NXP004 Patent
02Mar22 07:00 Nuformix Plc 3.99%
Nuformix PLC - Appointment of Dr Dan Gooding as Consultant
01Mar22 07:00 Nuformix Plc 3.99%
Nuformix PLC - Change of Auditor
08Feb22 07:00 Nuformix Plc 3.99%
Nuformix PLC - Oxilio NXP-001 formulation development contract
01Feb22 07:00 Nuformix Plc 3.99%
Nuformix PLC - Adviser Appointments
31Jan22 14:09 Nuformix Plc 3.99%
Nuformix PLC - Director/PDMR Shareholding
31Jan22 11:05 Nuformix Plc 3.99%
Nuformix PLC - Result of General Meeting
17Jan22 09:56 Nuformix Plc 3.99%
Nuformix PLC - Posting of Circular and Notice of General Meeting
10Jan22 16:23 Nuformix Plc 3.99%
Nuformix PLC - Director/PDMR Shareholding
14Dec21 07:01 Nuformix Plc 3.99%
Nuformix PLC - Subscription to raise £1.65 million
14Dec21 07:00 Nuformix Plc 3.99%
Nuformix PLC - Half year Report
25Nov21 07:00 Nuformix Plc 3.99%
Nuformix PLC - Positive pre-clinical data on NXP002
12Nov21 07:00 Nuformix Plc 3.99%
Nuformix PLC - NXP004 patent application filing
09Nov21 07:00 Nuformix Plc 3.99%
Nuformix PLC - Directorate Change
16Sep21 14:14 Nuformix Plc 3.99%
Nuformix PLC - Director/PDMR Shareholding - Replacement
16Sep21 12:47 Nuformix Plc 3.99%
Nuformix PLC - Director/PDMR Shareholding
13Sep21 07:00 Nuformix Plc 3.99%
Nuformix PLC - Licensing agreement with Oxilio for NXP001
24Aug21 11:57 Nuformix Plc 3.99%
Nuformix PLC - Result of AGM
23Jul21 13:35 Nuformix Plc 3.99%
Nuformix PLC - Posting of Annual Report and Notice of AGM
22Jul21 07:00 Nuformix Plc 3.99%
Nuformix PLC - Letter to shareholders re: Dr Anne Brindley
21Jul21 07:00 Nuformix Plc 3.99%
Nuformix PLC - Directorate Change
15Jul21 07:00 Nuformix Plc 3.99%
Nuformix PLC - Final results for the year ended 31 March 2021
07Jun21 07:00 Nuformix Plc 3.99%
Nuformix PLC - Notice of Allowance of Patent in US
01Jun21 07:00 Nuformix Plc 3.99%
Nuformix PLC - Project update - Progress on NXP002 and NXP004
24May21 07:00 Nuformix Plc 3.99%
Nuformix PLC - Directorate Changes
29Mar21 11:27 Nuformix Plc 3.99%
Result of General Meeting and Total Voting Rights
22Mar21 07:00 Nuformix Plc 3.99%
NXP001 (Oncology) - Exercise of Option by Oxilio
11Mar21 07:00 Nuformix Plc 3.99%
Initiation of research by Allenby Capital
10Mar21 07:00 Nuformix Plc 3.99%
Proposed Placing to raise £1.565 million
02Mar21 07:00 Nuformix Plc 3.99%
Research Results
10Feb21 07:00 Nuformix Plc 3.99%
Directorate Change
22Dec20 07:00 Nuformix Plc 3.99%
Appointment of Broker
22Dec20 07:00 Nuformix Plc 3.99%
Half-year Report
07Dec20 07:00 Nuformix Plc 3.99%
Appointment of Chief Executive Officer
02Dec20 07:00 Nuformix Plc 3.99%
Appointment of Non-Executive Director
24Nov20 07:00 Nuformix Plc 3.99%
Appointment of Non-Executive Director
07Oct20 07:00 Nuformix Plc 3.99%
Placing and Strategic Update
24Sep20 07:00 Nuformix Plc 3.99%
Exclusive Option Agreement for NXP001
20Aug20 11:33 Nuformix Plc 3.99%
Result of AGM
19Aug20 14:24 Nuformix Plc 3.99%
Results Pre-clinical Pilot Study in IPF for NXP004
28Jul20 12:14 Nuformix Plc 3.99%
Annual Report and Notice of AGM 2020
22Jul20 07:00 Nuformix Plc 3.99%
Preliminary Results for year ended 31 March 2020
01Jul20 11:15 Nuformix Plc 3.99%
Notification of Major Holdings
22Jun20 07:00 Nuformix Plc 3.99%
Board Change
27May20 07:00 Nuformix Plc 3.99%
Business Update
27May20 07:00 Nuformix Plc 3.99%
Nuformix and VistaGen Announce CNS Agreement
30Mar20 15:42 Nuformix Plc 3.99%
Notiication of Major Share Holding